Skip to content

Clinical trials

Adenocarcinoma trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Country / region: Russia Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20093
20103
20121
20161
20191
20202
20212
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
Eli Lilly and Company2
AO GENERIUM1
Abbott1
Boehringer Ingelheim1
Clovis Oncology, Inc.1
Daiichi Sankyo1
NantBioScience, Inc.1
NantCell, Inc.1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma16
Neoplasms6
Neoplasm Metastasis5
Stomach Neoplasms4
Carcinoma3
Digestive System Neoplasms3
Neoplasms by Histologic Type3
Carcinoma, Non-Small-Cell Lung2
Carcinoma, Renal Cell2
Digestive System Diseases2

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.